Inhibiting Norovirus Binding with Engineered Antibodies
Author Information
Author(s): Ettayebi Khalil, Hardy Michele E
Primary Institution: Montana State University
Hypothesis
Can engineered single-chain variable fragments (scFv) derived from a monoclonal antibody inhibit norovirus-like particle binding to cells?
Conclusion
The engineered scFv54.6 retains the ability to inhibit norovirus particle interactions with cells, suggesting its potential as a prophylactic strategy against outbreaks.
Supporting Evidence
- The scFv54.6 construct was successfully expressed in Pichia pastoris.
- scFv54.6 inhibited VLP-mediated hemagglutination in a dose-dependent manner.
- scFv54.6 blocked binding of rNV VLPs to CHO-FTBKE cells.
Takeaway
Scientists created a special protein that can stop a virus from sticking to cells, which could help prevent sickness during outbreaks.
Methodology
The study involved engineering a single-chain variable fragment (scFv) from a monoclonal antibody and testing its ability to inhibit norovirus-like particle binding to cells.
Limitations
The study does not address the stability of scFv54.6 in the gut or its effectiveness in vivo.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website